{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:08:54Z","timestamp":1790744934329,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["096816"],"award-info":[{"award-number":["096816"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AR120254"],"award-info":[{"award-number":["AR120254"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS085171"],"award-info":[{"award-number":["NS085171"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS29709"],"award-info":[{"award-number":["NS29709"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41591-019-0608-y","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T16:51:05Z","timestamp":1571676665000},"page":"1684-1690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency"],"prefix":"10.1038","volume":"25","author":[{"given":"Chien-Ju","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sgritta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqunae","family":"Mays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny Abraham","family":"Kaipparettu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Stoica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paymaan","family":"Jafar-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Noebels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-4732","authenticated-orcid":false,"given":"Mauro","family":"Costa-Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"608_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","volume":"17","author":"D Ehninger","year":"2011","unstructured":"Ehninger, D. & Silva, A. J. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol. Med. 17, 78\u201387 (2011).","journal-title":"Trends Mol. Med."},{"key":"608_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061747","volume":"41","author":"KD Winden","year":"2018","unstructured":"Winden, K. D., Ebrahimi-Fakhari, D. & Sahin, M. Abnormal mTOR activation in autism. Annu. Rev. Neurosci. 41, 1\u201323 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"608_CR3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/nn.3546","volume":"16","author":"M Costa-Mattioli","year":"2013","unstructured":"Costa-Mattioli, M. & Monteggia, L. M. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 16, 1537\u20131543 (2013).","journal-title":"Nat. Neurosci."},{"key":"608_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.conb.2012.05.004","volume":"22","author":"J Zhou","year":"2012","unstructured":"Zhou, J. & Parada, L. F. PTEN signaling in autism spectrum disorders. Curr. Opin. Neurobiol. 22, 873\u2013879 (2012).","journal-title":"Curr. Opin. Neurobiol."},{"key":"608_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tins.2016.11.008","volume":"40","author":"S Knafo","year":"2017","unstructured":"Knafo, S. & Esteban, J. A. PTEN: local and global modulation of neuronal function in health and disease. Trends Neurosci. 40, 83\u201391 (2017).","journal-title":"Trends Neurosci."},{"key":"608_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","volume":"135","author":"RJ Kelleher 3rd","year":"2008","unstructured":"Kelleher, R. J. 3rd & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401\u2013406 (2008).","journal-title":"Cell"},{"key":"608_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer, C. A. & Klann, E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67\u201375 (2010).","journal-title":"Trends Neurosci."},{"key":"608_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton, J. O. & Sahin, M. The neurology of mTOR. Neuron 84, 275\u2013291 (2014).","journal-title":"Neuron"},{"key":"608_CR9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471\u2013484 (2006).","journal-title":"Cell"},{"key":"608_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism and disease. Cell 169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"608_CR11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol."},{"key":"608_CR12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay, N. & Sonenberg, N. Upstream and downstream of mTOR.Genes Dev. 18, 1926\u20131945 (2004).","journal-title":"Genes Dev."},{"key":"608_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-neuro-071013-014100","volume":"37","author":"SA Buffington","year":"2014","unstructured":"Buffington, S. A., Huang, W. & Costa-Mattioli, M. Translational control in synaptic plasticity and cognitive dysfunction. Annu. Rev. Neurosci. 37, 17\u201338 (2014).","journal-title":"Annu. Rev. Neurosci."},{"key":"608_CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","volume":"12","author":"PB Crino","year":"2016","unstructured":"Crino, P. B. The mTOR signalling cascade: paving new roads to cure neurological diseaseNat. Rev. Neurol. 12, 379\u2013392 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"608_CR15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","volume":"29","author":"J Zhou","year":"2009","unstructured":"Zhou, J. et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29, 1773\u20131783 (2009).","journal-title":"J. Neurosci."},{"key":"608_CR16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","volume":"2","author":"MC Ljungberg","year":"2009","unstructured":"Ljungberg, M. C., Sunnen, C. N., Lugo, J. N., Anderson, A. E. & D\u2019Arcangelo, G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis. Models Mech. 2, 389\u2013398 (2009).","journal-title":"Dis. Models Mech."},{"key":"608_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/epi.12946","volume":"56","author":"LH Nguyen","year":"2015","unstructured":"Nguyen, L. H. et al. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia. Epilepsia 56, 636\u2013646 (2015).","journal-title":"Epilepsia"},{"key":"608_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ejhg.2013.114","volume":"22","author":"JA Hobert","year":"2014","unstructured":"Hobert, J. A., Embacher, R., Mester, J. L., Frazier, T. W.II & Eng, C. Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly. Eur. J. Hum. Genet 22, 273\u2013276 (2014).","journal-title":"Eur. J. Hum. Genet"},{"key":"608_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mp.2015.17","volume":"21","author":"AK Tilot","year":"2016","unstructured":"Tilot, A. K. et al. Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic autism spectrum disorder. Mol. Psychiatry 21, 118\u2013125 (2016).","journal-title":"Mol. Psychiatry"},{"key":"608_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/aur.132","volume":"3","author":"KL McBride","year":"2010","unstructured":"McBride, K. L. et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays\/mental retardation and macrocephaly.Autism Res. 3, 137\u2013141 (2010).","journal-title":"Autism Res."},{"key":"608_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-genom-090413-025600","volume":"15","author":"WF Hu","year":"2014","unstructured":"Hu, W. F., Chahrour, M. H. & Walsh, C. A. The diverse genetic landscape of neurodevelopmental disorders. Annu. Rev. Genomics Hum. Genet. 15, 195\u2013213 (2014).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"608_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.c.31401","volume":"166C","author":"GM Mirzaa","year":"2014","unstructured":"Mirzaa, G. M. & Poduri, A. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. Am. J. Med. Genet. C Semin. Med. Genet. 166C, 156\u2013172 (2014).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"608_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","volume":"50","author":"CH Kwon","year":"2006","unstructured":"Kwon, C. H. et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377\u2013388 (2006).","journal-title":"Neuron"},{"key":"608_CR24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng782","volume":"29","author":"SA Backman","year":"2001","unstructured":"Backman, S. A. et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte\u2013Duclos disease. Nat. Genet. 29, 396\u2013403 (2001).","journal-title":"Nat. Genet."},{"key":"608_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng781","volume":"29","author":"CH Kwon","year":"2001","unstructured":"Kwon, C. H. et al. Pten regulates neuronal soma size: a mouse model of Lhermitte\u2013Duclos disease. Nat. Genet. 29, 404\u2013411 (2001).","journal-title":"Nat. Genet."},{"key":"608_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-014-0223-x","volume":"29","author":"AP Ostendorf","year":"2015","unstructured":"Ostendorf, A. P. & Wong, M. mTOR inhibition in epilepsy: rationale and clinical perspectives. CNS Drugs 29, 91\u201399 (2015).","journal-title":"CNS Drugs"},{"key":"608_CR27","doi-asserted-by":"crossref","first-page":"a022756","DOI":"10.1101\/cshperspect.a022756","volume":"5","author":"JL Noebels","year":"2015","unstructured":"Noebels, J. L Single-gene determinants of epilepsy comorbidity. Cold Spring Harb. Perspect. Med. 5, a022756 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"608_CR28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0033291799008508","volume":"29","author":"E Fombonne","year":"1999","unstructured":"Fombonne, E. The epidemiology of autism: a review. Psychol. Med. 29, 769\u2013786 (1999).","journal-title":"Psychol. Med."},{"key":"608_CR29","first-page":"1","volume":"28","author":"TM Kazdoba","year":"2016","unstructured":"Kazdoba, T. M. et al. Translational mouse models of autism: advancing toward pharmacological therapeutics. Curr. Top. Behav. Neurosci. 28, 1\u201352 (2016).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"608_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuron.2013.03.016","volume":"78","author":"YH Jiang","year":"2013","unstructured":"Jiang, Y. H. & Ehlers, M. D. Modeling autism by SHANK gene mutations in mice. Neuron 78, 8\u201327 (2013).","journal-title":"Neuron"},{"key":"608_CR31","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association & American Psychiatric Association DSM-5 Task Force Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"608_CR32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10803-005-5035-x","volume":"35","author":"BR Lopez","year":"2005","unstructured":"Lopez, B. R., Lincoln, A. J., Ozonoff, S. & Lai, Z. Examining the relationship between executive functions and restricted, repetitive symptoms of autistic disorder. J. Autism Dev. Disord. 35, 445\u2013460 (2005).","journal-title":"J. Autism Dev. Disord."},{"key":"608_CR33","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1073\/pnas.1014715108","volume":"108","author":"L Stoica","year":"2011","unstructured":"Stoica, L. et al. Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl Acad. Sci. USA 108, 3791\u20133796 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"608_CR34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nn.3351","volume":"16","author":"W Huang","year":"2013","unstructured":"Huang, W. et al. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 16, 441\u2013448 (2013).","journal-title":"Nat. Neurosci."},{"key":"608_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","volume":"149","author":"I Garcia-Cao","year":"2012","unstructured":"Garcia-Cao, I. et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149, 49\u201362 (2012).","journal-title":"Cell"},{"key":"608_CR36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","volume":"15","author":"A Hagiwara","year":"2012","unstructured":"Hagiwara, A. et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase and SREBP1c. Cell Metab. 15, 725\u2013738 (2012).","journal-title":"Cell Metab."},{"key":"608_CR37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","volume":"18","author":"K Masui","year":"2013","unstructured":"Masui, K. et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 18, 726\u2013739 (2013).","journal-title":"Cell Metab."},{"key":"608_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1667","volume":"3","author":"G Panasyuk","year":"2012","unstructured":"Panasyuk, G. et al. PPAR\u03b3 contributes to PKM2 and HK2 expression in fatty liver. Nat. Commun. 3, 672 (2012).","journal-title":"Nat. Commun."},{"key":"608_CR39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2008.11.010","volume":"19","author":"RB Robey","year":"2009","unstructured":"Robey, R. B. & Hay, N. Is Akt the \u2018Warburg kinase\u2019? Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 19, 25\u201331 (2009).","journal-title":"Semin. Cancer Biol."},{"key":"608_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","volume":"14","author":"C Rinaldi","year":"2018","unstructured":"Rinaldi, C. & Wood, M. J. A. Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat. Rev. Neurol. 14, 9\u201321 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"608_CR41","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1074\/jbc.M210326200","volume":"278","author":"TA Vickers","year":"2003","unstructured":"Vickers, T. A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108\u20137118 (2003).","journal-title":"J. Biol. Chem."},{"key":"608_CR42","first-page":"383","volume":"51","author":"CL Cioffi","year":"1997","unstructured":"Cioffi, C. L. et al. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Mol. Pharmacol. 51, 383\u2013389 (1997).","journal-title":"Mol. Pharmacol."},{"key":"608_CR43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/78475","volume":"18","author":"H Zhang","year":"2000","unstructured":"Zhang, H. et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat. Biotechnol. 18, 862\u2013867 (2000).","journal-title":"Nat. Biotechnol."},{"key":"608_CR44","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"608_CR45","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.cell.2011.11.029","volume":"147","author":"PJ Zhu","year":"2011","unstructured":"Zhu, P. J. et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-\u03b3-mediated disinhibition. Cell 147, 1384\u20131396 (2011).","journal-title":"Cell"},{"key":"608_CR46","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.cell.2016.06.001","volume":"165","author":"SA Buffington","year":"2016","unstructured":"Buffington, S. A. et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165, 1762\u20131775 (2016).","journal-title":"Cell"},{"key":"608_CR47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","volume":"11","author":"JL Silverman","year":"2010","unstructured":"Silverman, J. L., Yang, M., Lord, C. & Crawley, J. N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490\u2013502 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"608_CR48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon, R. M. & Rawlins, J. N. T-maze alternation in the rodent. Nat. Protoc. 1, 7\u201312 (2006).","journal-title":"Nat. Protoc."},{"key":"608_CR49","volume":"5","author":"JL Johnson","year":"2015","unstructured":"Johnson, J. L., Huang, W., Roman, G. & Costa-Mattioli, M. TORC2: a novel target for treating age-associated memory impairment. Sci. Rep. 5, 15193 (2015).","journal-title":"Sci. Rep."},{"key":"608_CR50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41593-018-0156-7","volume":"21","author":"PJ Zhu","year":"2018","unstructured":"Zhu, P. J., Chen, C. J., Mays, J., Stoica, L. & Costa-Mattioli, M. mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. Nat. Neurosci. 21, 799\u2013802 (2018).","journal-title":"Nat. Neurosci."},{"key":"608_CR51","doi-asserted-by":"crossref","first-page":"e12052","DOI":"10.7554\/eLife.12052","volume":"5","author":"W Huang","year":"2016","unstructured":"Huang, W et al. Translational control by eIF2\u03b1 phosphorylation regulates vulnerability to the synaptic and behavioral effects of cocaine. eLife 5, e12052 (2016).","journal-title":"eLife"},{"key":"608_CR52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbabio.2009.07.008","volume":"1797","author":"Y Ma","year":"2010","unstructured":"Ma, Y., Bai, R. K., Trieu, R. & Wong, L. J. Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim. Biophys. Acta 1797, 29\u201337 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"608_CR53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-61779-504-6_4","volume":"837","author":"AE Frazier","year":"2012","unstructured":"Frazier, A. E. & Thorburn, D. R. Biochemical analyses of the electron transport chain complexes by spectrophotometry. Methods Mol. Biol. 837, 49\u201362 (2012).","journal-title":"Methods Mol. Biol."},{"key":"608_CR54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-61779-504-6_22","volume":"837","author":"V Venegas","year":"2012","unstructured":"Venegas, V. & Halberg, M. C. Measurement of mitochondrial DNA copy number. Methods Mol. Biol. 837, 327\u2013335 (2012).","journal-title":"Methods Mol. Biol."},{"key":"608_CR55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","volume":"35","author":"EE Swayze","year":"2007","unstructured":"Swayze, E. E. et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res. 35, 687\u2013700 (2007).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0608-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:00:18Z","timestamp":1684620018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0608-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1038\/s41591-019-0608-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.J.-N. and F.R. are employed by Ionis Pharmaceutical, a company that develops ASO therapies. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}